The National Institutes of Health (NIH) intends to award a non-competitive contract to Becton, Dickinson and Company for immunophenotyping and flow cytometric analysis of cellular populations. This procurement supports intramural research at the National Institute of Diabetes and Digestive and Kidney Diseases, requiring a dedicated flow cytometry system for routine and time-sensitive experimental workflows. The contract will be conducted under simplified acquisition procedures, with an amount not exceeding $350,000. Performance of services will occur at the NIH laboratory in Bethesda, Maryland. Interested parties must submit responses by June 22, 2026, demonstrating their capability to fulfill the requirement.